For providing post operative analgesia in total abdominal hysterectomy patients with traversus abdominal plane block with ropivacaine and dexmedetomidine
Not Applicable
Completed
- Conditions
- Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecifiedHealth Condition 2: null- ASA1/2
- Registration Number
- CTRI/2018/05/013681
- Lead Sponsor
- SDM COLLEGE OF MEDICAL SCIENCES AND HOSPITA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1 Patients undergoing elective abdominal hysterectomy
2 ASA 1 /2
3 Those are willing participate
Exclusion Criteria
1 Patient refusal
2 Patients with ASA III and IV
3 Patients with BMI < 18 kg/m2 and > 40 kg/m2
4 Local infection at the site of block
5 Allergy to study medications
6 Chronic use of pain medications or adrenoreceptor agonists or antagonists
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare analgesic effect of dexmedetomidine added to ropivacaine in TAP block vs dexmedetomidine given intravenously at the time of TAP block. <br/ ><br>Timepoint: Assesed pain score immediately after block <br/ ><br>15min, 30min,45min,60min,120min,4hrs 8 hr,12 hr 24hr
- Secondary Outcome Measures
Name Time Method To determine the total duration of analgesia <br/ ><br>2. To determine number of rescue analgesics used in 24 h <br/ ><br>3. To determine VAS scores in first 24 h <br/ ><br>4. To assess side effects of dexmedetomidine, if any <br/ ><br>Timepoint: 24HOURS